SCHEMBL24026164

SCHEMBL24026164

COc1ccc2c3c(ccc4c5ccccc5n(-c5ccccc5)c43)n(-c3ccccn3)c2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.39
DYRK1A Q13627 6/20 0.39
MAOA P21397 2/20 0.39
HTT P42858 3/20 0.39
MAPT P10636 2/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
HSD17B10 Q99714 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
EDNRA P25101 1/20 0.38
MAPK1 P28482 1/20 0.38
MAPK10 P53779 1/20 0.38
NCOA1 Q15788 1/20 0.38
NCOA3 Q9Y6Q9 1/20 0.38
FGFR1 P11362 1/20 0.38
PDE10A Q9Y233 2/20 0.38
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24026271 0.91 KDM4E (0.42) KDM4EHTTMAPTALDH1A1HPGD
SCHEMBL10027507 0.88 KDM4E (0.45) KDM4EHTTMAPTALDH1A1HPGD
SCHEMBL24026226 0.87 KDM4E (0.44) KDM4EDYRK1AMAOAHTTMAPT
SCHEMBL24026208 0.86 KDM4E (0.43) KDM4EDYRK1AMAOAHTTMAPT
SCHEMBL17248313 0.85 KDM4E (0.42) KDM4EHTTMAPTALDH1A1HPGD
SCHEMBL15063446 0.85 KDM4E (0.48) KDM4EDYRK1AMAOAHTTMAPT
SCHEMBL16999744 0.85 KDM4E (0.43) KDM4EALDH1A1L3MBTL1POLB
SCHEMBL15763795 0.84 KDM4E (0.40) KDM4EL3MBTL1
SCHEMBL24026163 0.84 KDM4E (0.37) KDM4EHTTMAPTHPGDMEN1
SCHEMBL17248296 0.83 KDM4E (0.36) KDM4EHTTMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210359224-A1 TETRADENTATE PLATINUM AND PALLADIUM COMPLEXES BASED ON BISCARBAZOLE AND ANALOGUES UNIV ARIZONA STATE (US) 2021-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210359224-A1 TETRADENTATE PLATINUM AND PALLADIUM COMPLEXES BASED ON BISCARBAZOLE AND ANALOGUES PDCD2L, PDCD1, PDCD4 KDM4E 3798/4885DYRK1A 1805/4885MAOA 2892/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.